Patients waiting over two years for access to EU- approved medicines
Irish approvals process delays mean public patients forced to wait for new therapies already available to private patients
Irish approvals process delays mean public patients forced to wait for new therapies already available to private patients
Ireland has delivered on creating pharma clusters but needs to focus more on innovation and next generation medicines, says Ipha
Waiving patent rights may have chilling effect on medicine development, industry warns
Industry says waiver of IP rights not needed as vaccine supply far outweighs demand
Just half of 41 cancer drugs approved from 2017-2020 were available here at end of 2021
Medicines regularly not worth approving at asking price
Upfront costs high but treatments may cut long-term expense and boost patient results
Two Ministers back US support for patent waiver opposed by pharmaceutical industry
New medicines have cut number of years of life lost to heart disease by 34% since 2005
Major drug manufacturers already at full capacity producing other medications
Deal with pharma sector comes as talks on new drug pricing deal deferred until May
Study finds high proportion of people willing to get immunised against coronavirus
Optimists say July. Others September. We will return – gradually – to a much changed world
Pharma group says eight cancer therapies awaiting HSE approval for over 900 days
Almost half surveyed say cancer is the disease science has greatest potential to cure
Government urged to improve focus on pharma research and access to medicines
Study examines access to 121 drugs approved since 2015 by EU regulator
Medicines generally blocked on basis of price as Ipha says delay ‘unacceptably long’
Spinraza is the latest in a series of controversial drugs that have put Ireland’s unique approval system in the spotlight
Row between industry and body that advises the HSE over access to market for new medicines
Revenue makes plans to avoid disruption to supplies after UK’s exit from the EU
Housing, health, property and environmental groups react to the budget
Pharma companies says drugs being exported to European markets but are not approved here
Cancer strategy targets ‘to be missed’ if new generation drugs not backed by Government
Government to save €15m this year as prices fall across 750 drugs
Simon Harris signs agreement to make innovative medicines available to Irish patients
Big pharma companies object to change that would allow generic manufacture of protected medicines for markets outside the bloc
Bernard Mallee appointed as IPHA’s director of communications and advocacy
Cancer drugs feature in list of therapies waiting HSE approval on cost grounds
Medicines for cancer, depression, heart disease to be used following HSE funding row
Drug companies told there is no budget and no plans for supplementary health budget
Department says it is considering three medicines for approval
Agreement testament to hard work of Cystic Fibrosis Ireland and patients, says Martin
Generics lobby says biosimilars are being blocked but pharma group disagrees
Annual savings of €78.4m predicted as result of agreement with drugs manufacturers
Drug manufacturers’ lobby group Ipha urges caution over study of competing treatments
Minister for Health says he would rather clinicians made decisions not politicians
Report reveals transfers by drug companies to healthcare organisations and professionals
Minister said companies charge State ‘unbelievably high prices’ for lifesaving drugs
European Commission rebuffs complaint by group representing Irish pharma companies
Talks on cuts have reached stalemate in recent weeks
The latest OECD study will not be very popular within the health service
Crosswords & puzzles to keep you challenged and entertained
Inquests into the nightclub fire that led to the deaths of 48 people
How does a post-Brexit world shape the identity and relationship of these islands
Weddings, Births, Deaths and other family notices